1. Olivieri, Michele, Cho, Tiffany, Álvarez-Quilón, Alejandro, Xu, Dongyi, Durocher, Daniel. 2020. A Genetic Map of the Response to DNA Damage in Human Cells. In Cell, 182, 481-496.e21. doi:10.1016/j.cell.2020.05.040. https://pubmed.ncbi.nlm.nih.gov/32649862/
2. Baccelli, Francesco, Leardini, Davide, Cerasi, Sara, Bertuccio, Salvatore Nicola, Masetti, Riccardo. 2023. ERCC6L2-related disease: a novel entity of bone marrow failure disorder with high risk of clonal evolution. In Annals of hematology, 102, 699-705. doi:10.1007/s00277-023-05128-2. https://pubmed.ncbi.nlm.nih.gov/36790458/
3. Sahoo, Sushree S, Kozyra, Emilia J, Wlodarski, Marcin W. 2020. Germline predisposition in myeloid neoplasms: Unique genetic and clinical features of GATA2 deficiency and SAMD9/SAMD9L syndromes. In Best practice & research. Clinical haematology, 33, 101197. doi:10.1016/j.beha.2020.101197. https://pubmed.ncbi.nlm.nih.gov/33038986/
4. Clark, Karen C, Wagner, Valerie A, Holl, Katie L, Grobe, Justin L, Kwitek, Anne E. 2022. Body Composition and Metabolic Changes in a Lyon Hypertensive Congenic Rat and Identification of Ercc6l2 as a Positional Candidate Gene. In Frontiers in genetics, 13, 903971. doi:10.3389/fgene.2022.903971. https://pubmed.ncbi.nlm.nih.gov/35812759/
5. Liu, Xiaojing, Liu, Tingting, Shang, Yafang, Liu, X Shirley, Meng, Fei-Long. 2020. ERCC6L2 promotes DNA orientation-specific recombination in mammalian cells. In Cell research, 30, 732-744. doi:10.1038/s41422-020-0328-3. https://pubmed.ncbi.nlm.nih.gov/32355287/
6. Dardiotis, Efthimios, Karampinis, Emmanouil, Siokas, Vasileios, Bogdanos, Dimitrios P, Hadjigeorgiou, Georgios M. 2019. ERCC6L2 rs591486 polymorphism and risk for amyotrophic lateral sclerosis in Greek population. In Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 40, 1237-1244. doi:10.1007/s10072-019-03825-3. https://pubmed.ncbi.nlm.nih.gov/30879219/